(Q38078245)

28 August 2017

1 reference

title

Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool (English)

1 reference

28 August 2017

0 references

Sadaf Moeez

1

1 reference

28 August 2017

Peter John

series ordinal

2

1 reference

28 August 2017

Attya Bhatti

series ordinal

3

1 reference

28 August 2017

publication date

1 February 2013

1 reference

Rheumatology International

28 August 2017

published in

1 reference

28 August 2017

volume

33

1 reference

28 August 2017

issue

7

1 reference

28 August 2017

page(s)

1669-1673

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-012-2635-6

28 August 2017

exact match

0 references

cites work

Epidemiology of adult rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Antibodies to citrullinated proteins in arthritis: pathology and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Tyrosine kinases in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Treating very early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

RETRACTED: Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Long-term outcome of treating rheumatoid arthritis: results after 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Therapeutic strategies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Autoantibodies in rheumatoid arthritis and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Anti-keratin antibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-012-2635-6

Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA

21 January 2018

1 reference

12 December 2020

Prognostic criteria in rheumatoid arthritis: can we predict which patients will require specific anti-rheumatoid treatment?

1 reference

12 December 2020

Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis

1 reference

12 December 2020

Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease

1 reference

12 December 2020

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

1 reference

12 December 2020

Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later

1 reference

12 December 2020

The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing

1 reference

12 December 2020

The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia

1 reference

12 December 2020

Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness

1 reference

12 December 2020

Genetic interrelationship between insulin-dependent diabetes mellitus, the autoimmune thyroid diseases, and rheumatoid arthritis

1 reference

12 December 2020

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis

1 reference

12 December 2020

10.1007/S00296-012-2635-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1011386759

0 references

1 reference